• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例3型进行性家族性肝内胆汁淤积症

A Case of Progressive Familial Intrahepatic Cholestasis Type-3.

作者信息

Bhatt Jaladhi V, Akhoury Ambika, Vekaria Vaidehi V, Parmar Hardik R, Patel Dhruval N

机构信息

Pediatrics and Neonatology, Narendra Modi Medical College and Sheth LG Hospital, Ahmedabad, IND.

Pediatrics, Shri Atal Bihari Vajpayee Medical College and Research Institute, Bangalore, IND.

出版信息

Cureus. 2024 Oct 31;16(10):e72782. doi: 10.7759/cureus.72782. eCollection 2024 Oct.

DOI:10.7759/cureus.72782
PMID:39618628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11608084/
Abstract

Progressive familial intrahepatic cholestasis (PFIC) is a rare autosomal recessive disorder marked by severe, early-onset cholestasis due to genetic mutations in hepatobiliary transporters, leading to toxic bile acid accumulation and liver damage. PFIC is categorized into three types based on mutations in , , and genes. This case involves a five-year-old female with symptoms such as easy fatigability, coarse facial features, respiratory distress, pruritus, abdominal distension, dark-colored urine, pale stool, and generalized edema. The patient, born to consanguineous parents with a family history of similar symptoms, showed severe pallor, icterus, clubbing, generalized edema, hepatomegaly, splenomegaly, and ascites on examination. Laboratory findings indicated severe anemia, thrombocytopenia, conjugated hyperbilirubinemia, low protein and albumin levels, and elevated liver enzymes. Imaging confirmed liver and spleen enlargement, ascites, and cardiomegaly. Genetic testing revealed a homozygous deletion in the gene, diagnosing PFIC type 3. Treatment included ursodeoxycholic acid, fat-soluble vitamins, propranolol, intravenous albumin, fresh frozen plasma, and red cell transfusions. The patient was referred for further gastroenterological management and potential liver transplantation, and the family received genetic counseling. This case highlights the critical role of genetic testing in diagnosing and managing PFIC and the necessity of early identification and multidisciplinary care for such complex genetic disorders.

摘要

进行性家族性肝内胆汁淤积症(PFIC)是一种罕见的常染色体隐性疾病,其特征为由于肝胆转运蛋白基因突变导致严重的早发性胆汁淤积,进而引起毒性胆汁酸蓄积和肝损伤。根据ATP8B1、ABCB11和ABCC2基因的突变情况,PFIC可分为三种类型。该病例为一名五岁女性,有易疲劳、面容粗糙、呼吸窘迫、瘙痒、腹胀、尿色深、粪便色淡及全身水肿等症状。患者父母为近亲结婚,有类似症状的家族史,检查发现其面色严重苍白、黄疸、杵状指、全身水肿、肝肿大、脾肿大及腹水。实验室检查结果显示严重贫血、血小板减少、结合胆红素血症、低蛋白和白蛋白水平以及肝酶升高。影像学检查证实肝脏和脾脏肿大、腹水及心脏扩大。基因检测发现ATP8B1基因存在纯合缺失,诊断为3型PFIC。治疗包括熊去氧胆酸、脂溶性维生素、普萘洛尔、静脉输注白蛋白、新鲜冰冻血浆及红细胞输注。患者被转诊接受进一步的胃肠病学治疗及可能的肝移植,其家人接受了遗传咨询。该病例突出了基因检测在PFIC诊断和管理中的关键作用,以及对于此类复杂遗传疾病进行早期识别和多学科护理的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/11608084/71d34a3654c4/cureus-0016-00000072782-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/11608084/71d34a3654c4/cureus-0016-00000072782-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f963/11608084/71d34a3654c4/cureus-0016-00000072782-i01.jpg

相似文献

1
A Case of Progressive Familial Intrahepatic Cholestasis Type-3.一例3型进行性家族性肝内胆汁淤积症
Cureus. 2024 Oct 31;16(10):e72782. doi: 10.7759/cureus.72782. eCollection 2024 Oct.
2
Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.ATP8B1、ABCB11和ABCB4的杂合突变在一个儿科队列中导致轻度形式的进行性家族性肝内胆汁淤积症。
Gastroenterol Hepatol. 2022 Oct;45(8):585-592. doi: 10.1016/j.gastrohep.2021.12.005. Epub 2021 Dec 20.
3
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
J Clin Exp Hepatol. 2014 Mar;4(1):25-36. doi: 10.1016/j.jceh.2013.10.005. Epub 2013 Nov 23.
4
Molecular overview of progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症的分子概述
World J Gastroenterol. 2020 Dec 21;26(47):7470-7484. doi: 10.3748/wjg.v26.i47.7470.
5
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症。
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S26-35. doi: 10.1016/S2210-7401(12)70018-9.
6
Novel ABCB4 mutation in a female patient with progressive familial intrahepatic cholestasis type 3: a case report and literature review.一名患有3型进行性家族性肝内胆汁淤积症的女性患者中的新型ABCB4突变:病例报告及文献综述
Ann Med Surg (Lond). 2024 Dec 19;87(2):953-963. doi: 10.1097/MS9.0000000000002813. eCollection 2025 Feb.
7
A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.3 型进行性家族性肝内胆汁淤积症的一名女性患者,其致病原因为 ABCB4 基因突变杂合子,经熊去氧胆酸治疗后肝硬化得到改善:病例报告。
BMC Med Genomics. 2023 Jul 25;16(1):171. doi: 10.1186/s12920-023-01602-y.
8
Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of .病例报告:一例罕见的青年成人3型进行性家族性肝内胆汁淤积症,伴有一种新的杂合致病性变异。
Front Pediatr. 2022 Oct 18;10:1012825. doi: 10.3389/fped.2022.1012825. eCollection 2022.
9
The molecular landscape of progressive familial intrahepatic cholestasis in Turkey: Defining the molecular profiles and expanding the variant spectrum.土耳其进行性家族性肝内胆汁淤积症的分子特征:定义分子谱并扩展变异谱。
Ann Hum Genet. 2022 May;86(3):119-126. doi: 10.1111/ahg.12456. Epub 2021 Dec 28.
10
Systematic review of progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症的系统评价。
Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):20-36. doi: 10.1016/j.clinre.2018.07.010. Epub 2018 Sep 17.

本文引用的文献

1
Genetic Analysis of Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis.与低磷脂相关胆石病发病机制和病理生理学相关的突变和变异的遗传分析。
Genes (Basel). 2022 Jun 11;13(6):1047. doi: 10.3390/genes13061047.
2
Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review.进行性家族性肝内胆汁淤积症的流行病学和负担:系统评价。
Orphanet J Rare Dis. 2021 Jun 3;16(1):255. doi: 10.1186/s13023-021-01884-4.
3
Molecular overview of progressive familial intrahepatic cholestasis.
进行性家族性肝内胆汁淤积症的分子概述
World J Gastroenterol. 2020 Dec 21;26(47):7470-7484. doi: 10.3748/wjg.v26.i47.7470.
4
Familial intrahepatic cholestasis: New and wide perspectives.家族性肝内胆汁淤积症:新的广阔视角。
Dig Liver Dis. 2019 Jul;51(7):922-933. doi: 10.1016/j.dld.2019.04.013. Epub 2019 May 16.
5
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
J Clin Exp Hepatol. 2014 Mar;4(1):25-36. doi: 10.1016/j.jceh.2013.10.005. Epub 2013 Nov 23.
6
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症。
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S26-35. doi: 10.1016/S2210-7401(12)70018-9.
7
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
Orphanet J Rare Dis. 2009 Jan 8;4:1. doi: 10.1186/1750-1172-4-1.
8
Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene.低磷脂相关胆石症:与MDR3/ABCB4基因突变的关联。
Orphanet J Rare Dis. 2007 Jun 11;2:29. doi: 10.1186/1750-1172-2-29.
9
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症一种亚型中多药耐药3基因表达缺陷
Hepatology. 1996 Apr;23(4):904-8. doi: 10.1002/hep.510230435.